Scholarlink

<p>This study evaluated the protective effects of celecoxib on epilepsy and explore its potential involvement in regulating pyroptosis and the high mobility group box 1 (HMGB1)/Toll-like receptor 4 (TLR4) signaling pathway. Adult male Sprague–Dawley rats were injected with ferrous chloride (FeCl<sub>2</sub>) with or without celecoxib for 7 consecutive days. After sacrifice, tissues were collected for neurological function assessments, magnetic resonance imaging, and multiple tissue analyses. Intracerebral injection of FeCl<sub>2</sub> in rats induced severe seizures, microglial recruitment and polarization, ferroptosis, pyroptosis, and inflammation in the frontal cortex. In the hippocampus, FeCl<sub>2</sub> injection led to neuronal loss, reduced synaptic complexity, and aberrant HMGB1 expression. Celecoxib treatment delayed seizure onset and significantly reduced the severity and duration of seizures, the extent of injury, and neurological impairments caused by FeCl<sub>2</sub> exposure. These effects were mediated through the suppression of HMGB1/TLR4 signaling and inhibition of key pro-inflammatory cytokines. Celecoxib treatment mitigated neuronal loss, improved synaptic complexity, stabilized microglial activity, inhibited astrocyte proliferation, and modulated HMGB1 expression. In conclusion, celecoxib effectively attenuated FeCl<sub>2</sub>-induced inflammation and neural injury partially by inhibiting the HMGB1/TLR4 pathway, thereby suppressing pyroptosis and reactive gliosis. These effects improved seizure, highlighting the therapeutic potential of celecoxib for managing epilepsy following hemorrhagic brain injury.</p> Graphical Abstract <p><b>Title:</b> Molecular pathological mechanisms of acute brain injury involving brain parenchymal and vascular damage</p> <p><b>Legend:</b> Intracranial hemorrhage activates PAMPs and PRPs, whereas iron ions promote ROS accumulation, resulting in the downregulation of GSH and GPX4, ultimately inducing ferroptosis. HMGB1, released in response to brain parenchymal damage. binds to TLR4, triggering a robust inflammatory cascade that contributes to pyroptosis and neuroinflammation.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neuroprotective Effects of the Nonsteroidal Anti-inflammatory Drug Celecoxib Against Caspase-1-dependent Pyroptosis Partially by Suppressing the HMGB1/TLR4 Pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月23日

查看全文
  • Yu Sun,
  • Shucai Jiang,
  • Yan Feng,
  • Lei Chen,
  • Zhe Feng,
  • Caibin Gao,
  • Weifang Rong,
  • Feng Wang

摘要

This study evaluated the protective effects of celecoxib on epilepsy and explore its potential involvement in regulating pyroptosis and the high mobility group box 1 (HMGB1)/Toll-like receptor 4 (TLR4) signaling pathway. Adult male Sprague–Dawley rats were injected with ferrous chloride (FeCl2) with or without celecoxib for 7 consecutive days. After sacrifice, tissues were collected for neurological function assessments, magnetic resonance imaging, and multiple tissue analyses. Intracerebral injection of FeCl2 in rats induced severe seizures, microglial recruitment and polarization, ferroptosis, pyroptosis, and inflammation in the frontal cortex. In the hippocampus, FeCl2 injection led to neuronal loss, reduced synaptic complexity, and aberrant HMGB1 expression. Celecoxib treatment delayed seizure onset and significantly reduced the severity and duration of seizures, the extent of injury, and neurological impairments caused by FeCl2 exposure. These effects were mediated through the suppression of HMGB1/TLR4 signaling and inhibition of key pro-inflammatory cytokines. Celecoxib treatment mitigated neuronal loss, improved synaptic complexity, stabilized microglial activity, inhibited astrocyte proliferation, and modulated HMGB1 expression. In conclusion, celecoxib effectively attenuated FeCl2-induced inflammation and neural injury partially by inhibiting the HMGB1/TLR4 pathway, thereby suppressing pyroptosis and reactive gliosis. These effects improved seizure, highlighting the therapeutic potential of celecoxib for managing epilepsy following hemorrhagic brain injury.

Graphical Abstract

Title: Molecular pathological mechanisms of acute brain injury involving brain parenchymal and vascular damage

Legend: Intracranial hemorrhage activates PAMPs and PRPs, whereas iron ions promote ROS accumulation, resulting in the downregulation of GSH and GPX4, ultimately inducing ferroptosis. HMGB1, released in response to brain parenchymal damage. binds to TLR4, triggering a robust inflammatory cascade that contributes to pyroptosis and neuroinflammation.